Effect of supplemental oxygen exposure on myocardial injury in ST-elevation myocardial infarction

Heart

Volumn 102, Issue 6, 2016, Pages 444-451

  Nehme, Ziad ^a,b   Stub, Dion ^b,c,d,e   Bernard, Stephen ^a,b,c   Stephenson, Michael ^a   Bray, Janet E ^b,c   Cameron, Peter ^b,c   Meredith, Ian T ^f   Barger, Bill ^a   Ellims, Andris H ^c,d   Taylor, Andrew J ^c,d   Kaye, David M ^b,c,d   Smith, Karen ^a,b,g  

^a Ambulance Victoria   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e WESTERN HEALTH   (Australia)

^f MONASH MEDICAL CENTRE   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; OXYGEN; TROPONIN; TROPONIN I;

ADULT; ARTICLE; BREATHING; CARDIOGENIC SHOCK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DOSE RESPONSE; ENZYME RELEASE; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OXYGEN THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT DURATION; CARDIAC MUSCLE; CAUSE OF DEATH; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY; FOLLOW UP; METABOLISM; MORTALITY; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROCEDURES; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS; VICTORIA; WESTERN AUSTRALIA;

CAUSE OF DEATH; CREATINE KINASE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; OXYGEN INHALATION THERAPY; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; TROPONIN I; VICTORIA; WESTERN AUSTRALIA;

EID: 84960947738     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-308636     Document Type: Article

References (20)

1. Rawles JM, Kenmure AC. Controlled trial of oxygen in uncomplicated myocardial infarction. BMJ 1976;1:1121-3.
2. Stub D, Smith K, Bernard S, et al. Air versus oxygen in ST-segment elevation myocardial infarction. Circulation 2015;131:2143-50.
3. Farquhar H, Weatherall M, Wijesinghe M, et al. Systematic review of studies of the effect of hyperoxia on coronary blood flow. Am Heart J 2009;158:371-7.
4. Beasley R, Aldington S, Weatherall M, et al. Oxygen therapy in myocardial infarction: An historical perspective. J R Soc Med 2007;100:130-3.
5. McNulty PH, Robertson BJ, Tulli MA, et al. Effect of hyperoxia and vitamin C on coronary blood flow in patients with ischemic heart disease. J Appl Physiol 2007;102:2040-5.
6. Mak S, Azevedo ER, Liu PP, et al. Effect of hyperoxia on left ventricular function and filling preures in patients with and without congestive heart failure. Chest 2001;120:467-73.
7. Kenmure AC, Murdoch WR, Beattie AD, et al. Circulatory and metabolic effects of oxygen in myocardial infarction. BMJ 1968;4:360-4.
8. Ranchord AM, Argyle R, Beynon R, et al. High-concentration versus titrated oxygen therapy in ST-elevation myocardial infarction: A pilot randomized controlled trial. Am Heart J 2012;163:168-75.
9. Stub D, Smith K, Bernard S, et al. A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Verses Oxygen in myocarDial infarction study (AVOID Study). Am Heart J 2012;163: 339-45e1.
10. Hofmann R, James SK, Svenon L, et al. DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial. Am Heart J 2014;167: 322-8.
11. Rubin DB, Schenker N. Multiple imputation in health-care databases: An overview and some applications. Stat Med 1991;10:585-98.
12. White IR, Royston P, Wood AM. Multiple imputation using chained equations: iues and guidance for practice. Stat Med 2011;30:377-99.
13. Chia S, Senatore F, Raffel OC, et al. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2008;1:415-23.
14. Stevens TP, Dylag A, Panthagani I, et al. Effect of cumulative oxygen exposure on respiratory symptoms during infancy among VLBW infants without bronchopulmonary dysplasia. Pediatr Pulmonol 2010;45:371-9.
15. Elmer J, Wang B, Melhem S, et al. Exposure to high concentrations of inspired oxygen does not worsen lung injury after cardiac arrest. Crit Care 2015; 19:105.
16. Zweier JL, Talukder MA. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006;70:181-90.
17. Brueckl C, Kaestle S, Kerem A, et al. Hyperoxia-induced reactive oxygen species formation in pulmonary capillary endothelial cells in situ. Am J Respir Cell Mol Biol 2006;34:453-63.
18. Mach WJ, Thimmesch AR, Pierce JT, et al. Consequences of hyperoxia and the toxicity of oxygen in the lung. Nurs Res Pract 2011;2011:260482.
19. Moradkhan R, Sinoway LI. Revisiting the role of oxygen therapy in cardiac patients. JACC 2010;56:1013-6.
20. McNulty PH, King N, Scott S, et al. Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization. Am J Physiol Heart Circ Physiol 2005;288:H1057-62.